Insider · CIK 0001724161

Vacirca Jeff L

Reports to the SEC for 4 companies · IRVING, TX

sec.gov

Transactions

Companies

Filings

CIK

0001724161

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-14	CAICaris Life Sciences, Inc.A Award	Director	AAward	+13.2K sh	—	—	62,863
2026-05-11	CAICaris Life Sciences, Inc.P Purchase	Director	PPurchase	+31.1K sh	$16.15	+$501K	49,671
2026-02-26	CAICaris Life Sciences, Inc.A Award	Director	AAward	+2,492 sh	$20.06	+$50K	18,621
2024-06-11	ASRTAssertio Holdings, Inc.P Purchase	Director	PPurchase	+10K sh	$1.11	+$11.1K	151,159
2024-05-23	ASRTAssertio Holdings, Inc.A Award	Director	AAward	+53.8K sh	—	—	141,159
2024-05-23	ASRTAssertio Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+81.2K sh	—	—	81,225
2023-07-31	SPECTRUM PHARMACEUTICALS INCD Disposition to Issuer	Director	DDisposition to Issuer	−295K sh	—	—	0
2023-07-31	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−75K sh	—	—	0
2023-07-31	ASRTAssertio Holdings, Inc.A Award	Director	AAward	+52.6K sh	—	—	52,642
2023-07-31	ASRTAssertio Holdings, Inc.A Award	Director	AAward	+34.8K sh	—	—	87,409
2023-07-31	ASRTAssertio Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,005 sh	—	—	5,005
2022-11-30	SPECTRUM PHARMACEUTICALS INCP Purchase	Director	PPurchase	+50K sh	$0.45	+$22.5K	270,244
2022-10-27	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+50K sh	$0.43	+$21.5K	220,244
2022-08-31	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+25K sh	—	—	195,244
2022-08-31	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2022-02-14	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+10K sh	$0.68	+$6,849	170,244
2021-06-17	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+14.3K sh	—	—	160,244
2021-06-17	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+67.8K sh	—	—	67,804
2021-04-07	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+20K sh	$3.15	+$63K	145,967
2021-02-17	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+10K sh	$3.61	+$36.1K	125,967
2020-12-24	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+10K sh	$3.79	+$37.9K	115,967
2020-11-09	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+10K sh	$3.78	+$37.8K	105,967
2020-09-16	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+1,000 sh	$4.24	+$4,238.1	95,967
2020-08-28	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+20K sh	$4.08	+$81.6K	94,967
2020-06-30	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+8,000 sh	$3.21	+$25.7K	74,967
2020-06-18	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+30K sh	—	—	66,967
2020-06-18	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+60K sh	—	—	60,000
2020-05-15	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+5,000 sh	$3.11	+$15.6K	36,967
2019-06-26	Odonate Therapeutics, Inc.P Purchase	Director	PPurchase	+19.2K sh	$26.00	+$500K	23,231
2019-06-20	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+10K sh	—	—	31,967
2019-06-20	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2019-05-13	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+1,000 sh	$8.93	+$8,930	21,967
2019-03-18	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+2,000 sh	$10.47	+$20.9K	20,967
2019-03-15	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+2,000 sh	$9.62	+$19.2K	18,967
2019-03-04	Odonate Therapeutics, Inc.P Purchase	Director	PPurchase	+2,000 sh	$17.00	+$34K	3,000
2019-03-04	Odonate Therapeutics, Inc.P Purchase	Director	PPurchase	+1,000 sh	$17.00	+$17K	4,000
2018-12-31	Odonate Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2018-11-30	SPECTRUM PHARMACEUTICALS INCA Award	Director	AAward	+6,667 sh	—	—	16,967
2018-11-30	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+14.5K sh	—	—	14,507
2018-01-02	Odonate Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2017-12-12	Odonate Therapeutics, Inc.P Purchase	Director	PPurchase	+1,000 sh	$23.30	+$23.3K	1,000

Recent filings

Accepted (ET)
Aug 144
Vacirca Jeff L0001724161-26-000008
SEC(opens sec.gov)
May 124
Vacirca Jeff L0001724161-26-000005
SEC(opens sec.gov)
Feb 274
Vacirca Jeff L0001724161-26-000002
SEC(opens sec.gov)
Jun 124
Vacirca Jeff L0001104659-24-070931
SEC(opens sec.gov)
May 284
Vacirca Jeff L0001104659-24-065700
SEC(opens sec.gov)
Aug 24
Vacirca Jeff L0001104659-23-086925
SEC(opens sec.gov)
Aug 14
Vacirca Jeff L0000899243-23-017668
SEC(opens sec.gov)
Dec 24
Vacirca Jeff L0000899243-22-037526
SEC(opens sec.gov)
Oct 274
Vacirca Jeff L0001209191-22-054744
SEC(opens sec.gov)
Sep 24
Vacirca Jeff L0001209191-22-048523
SEC(opens sec.gov)
Feb 144
Vacirca Jeff L0001209191-22-009266
SEC(opens sec.gov)
Jun 224
Vacirca Jeff L0001209191-21-042495
SEC(opens sec.gov)
Apr 84
Vacirca Jeff L0001209191-21-026029
SEC(opens sec.gov)
Feb 184
Vacirca Jeff L0001209191-21-011890
SEC(opens sec.gov)

Companies

Address

C/O CARIS LIFE SCIENCES, INC. 750 W. JOHN CARPENTER FREEWAY, SUITE 800

IRVING, TX, 75039